Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Liver Disease Article
This is a selection made from among articles on Drug Treatment Liver Disease. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Alcohol And Drug Treatment: Do You Know Someone Struggling With Addiction?
By John Wellington
Do you like an occasional beer, or maybe a sip of wine? Alcohol consumption in moderation is not a problem per se. We all love to unwind with a fine wine or frosty brew. However, too many individuals take this leisurely habit to a whole new level. How much alcohol is too much? Well, if you don't know, then you might want to do a reality check. Don't make the mistake of becoming too easy-going with your social life.
Too many college kids do this with drinking and partying and none of them end up happy I can tell you. One glass, two glass and before they know it, only gulping down a case a night can satisfy their crave. It's time to be well-informed, people. You have to control how much you drink and how often. If you don't, then you just may end up in an alcohol and drug treatment program. I don’t think it’s fun in there.
Back in high school I watched a number of kids drink alcohol like it was milk. Where were they getting all those booze? I mean come on; someone had to be supplying it to them. They were clearly under the drinking age at the time. Regardless of where the supplies came from, they were chugging like there was no tomorrow. Some teens just think this is the only way to have fun and look cool. It’s a way to escape I guess. It's their vehicle to a less stressful realm. Unfortunately it's not healthy. People need to focus their energy on more legal and safer routes to a good time. No one wants to end up in an alcohol and drug treatment program.
Talking about alcohol and drug treatment programs, a close friend of mine was in one. I met him about seven years back, while working at a video store. It took me a while to realize that he had spent a mere 20 years on this earth. This amazed me when I found out because he was always carrying cases of beer in his car. He told me once that he drinks around 20 beers each night. I thought to myself, "God, this kid's an alcoholic, and he's not even old enough to buy it." That's crazy! However, there are many people out there in the same condition. Eventually he engaged the service of an alcohol and drug treatment program. These days he is alcohol free.
Do you or someone you love need the assistance of an alcohol and drug treatment program? If so, you can go on the Internet now and find the answers you're looking for. There are alcohol and drug treatment centers just around the corner. Get that much-needed help today. This is your future we're talking about here. Don’t drown it in endless drinking nights again.
John Wellington provides readers with up-to-date commentaries, articles, and reviews for health, skin care, and other related information.
Article Source: http://EzineArticles.com/?expert=John_Wellington
http://EzineArticles.com/?Alcohol-And-Drug-Treatment:-Do-You-Know-Someone-Struggling-With-Addiction?&id=306355
Drug Treatment Liver Disease Specific links
Drug Treatment Liver Disease News
Mixed Messages on Rare Disease Drug
An FDA advisory panel said a study of Vyndaqel for familial amyloid polyneuropathy did not provide proof of its benefit, but that proof may not be necessary.
Read more...UAB study to help fight liver disease
Monthly gatherings offer exposure to careers and encouragement.
Read more...FDA approves Protalix's Gaucher drug Elelyso
The Food and Drug Administration on Tuesday approved a new treatment for Gaucher disease, a rare genetic disorder that can cause liver and neurological problems.The new drug is called Elelyso. It was developed ...
Read more...FDA staff shoots down Pfizer rare disease drug
WASHINGTON (Reuters) - Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff reviewed the pill, tafamidis, ahead of an advisory panel of outside experts, which on Thursday will vote on whether to recommend it for approval. The FDA will make a final ...
Read more...New research examines impact of liver disease
Research being presented at Digestive Disease Week® offers insights into the progression of diseases leading to liver damage, which affect diverse populations, including young people. Studies show that the increasing rates of obesity are putting teens at risk for developing nonalcoholic fatty liver disease and are decreasing the availability of healthy livers for organ donations, which are ...
Read more...Pfizer Rare Disease Drug Slammed By FDA Reviewer
An FDA panel tomorrow will review a Pfizer drug called Tafamidis that is designed to treat familial amyloid polyneuropathy, a rare and progressively fatal genetic neurodegenerative disease. But agency briefing documents do not offer a good prognosis - an FDA medical reviewer bluntly suggests the drug should not be approved right now
Read more...FDA panel recommends anti-HIV drug
A drug already approved for treatment of AIDS might one day be approved for prevention of the deadly disease in individuals at high risk.
Read more...J&J drug shows promise in high-risk prostate cancer
(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months of treatment with the combination therapy completely or nearly eliminated the cancer in a third of patients, all of whom had localized ...
Read more...HIV prevention drug recommended
A drug already approved for treatment of AIDS might one day be approved for prevention of the deadly disease in individuals at high risk.
Read more...Pfizer Enters Market For Super-Expensive, Ultra-Rare Disease Drugs ??? With A Price Cut
and its partner, Protalix BioTherapeutics, just got some good news from the Food and Drug Administration: Elelyso, a treatment for a rare genetic disorder called Gaucher disease, was approved. Because the disease is so rare, the drug was tested in only 56 patients in its late-stage clinical trials. In the words of the FDA: Gaucher ...
Read more...